After 16 months of interim leadership, Francisco Rossi has been appointed as the new director of Invima, the Colombian National Institute for Food and Drug Surveillance. This appointment has been met with approval from pharmaceutical associations, who are optimistic about Rossi’s ability to address the challenges facing Invima.
María Clara Escobar, president of Afidro, praised Dr. Rossi’s career and expressed confidence in his leadership. She highlighted the urgency of addressing delays in procedures and the need for modernization within the entity. Afidro expects Rossi to work on a medium and long-term action plan in collaboration with all interested parties, incorporating the vision of other reference agencies and promoting pharmaceutical innovation for the benefit of the health system and patients.
The Colombian Association of the Pharmaceutical Industry also celebrated the appointment of Rossi as director of Invima, considering it an important step towards health autonomy. Clara Isabel Rodríguez, executive director of ASCIF, expressed the willingness of the local pharmaceutical industry to collaborate in increasing the production capacity of medicines in the country in coordination with the relevant authorities.
In response to reported shortages of medicines, Invima issued an alert about the responsibilities in the industry. The entity urged importers and producers of medicines to respond to the requirements that have been made to establish whether or not there is support for the shortage of medicines in the country and seek a solution to this problem.
Despite the fact that there has been a shortage of drugs for several months, the actors in charge of providing the drugs have not provided clear information about the problem. Invima made an urgent call to importers and producers to respond immediately to the requirements that have been made via email, in accordance with statutory law 1751 of 2015, which regulates the fundamental right to health.
In conclusion, the appointment of Francisco Rossi as the new director of Invima has been met with approval from pharmaceutical associations, who are optimistic about his ability to address the challenges facing the entity. There is also a call for importers and producers of medicines to respond to the requirements made by Invima in order to address the reported shortages of medicines in the country.
Image Source: www.infobae.com
Health, Business, Politics